Akumin announces US $35M bought deal
Akumin (TSX: AKU.U) engaged Clarus Securities Inc. for a bought deal of 8,750,000 Common Shares at US $4.00 for gross proceeds of US $35,000,000
Cannex Capital to acquire Ametrine Wellness/Jetty Extracts
Cannex Capital Holdings Inc. (CSE: CNNX) signed a binding letter agreement to acquire 100% of Oakland, California based Ametrine Wellness Inc. dba Jetty Extracts
Cannabis Wheaton Income to acquire Robinson’s Cannabis
Cannabis Wheaton Income (TSX-V: CBW) to acquire all of the issued and outstanding shares of Robinson’s Cannabis Incorporated in an all-stock transaction
DiaMedica Therapeutics closes US $2.5M final tranche of private placemet
DiaMedica Therapeutics (TSX-V: DMA; OTCQB: DMCAF) closed second and final tranche of offering for gross proceeds of approximately US$2.5M. The company raised US $6.3M in two tranches.
Xenon Pharmaceuticals closes Teva and BVF transactions
Xenon Pharmaceuticals (NASDAQ: XENE) terminated collaborative development and license agreement with Teva Pharmaceuticals and closed share exchange transaction with Biotechnology Value Fund (BVF)
Solarvest BioEnergy closes private placement
Solarvest BioEnergy Inc. (TSX-V: SVS) closed previously announced financing, issuing convertible debentures units for the aggregate gross proceeds of $1,000,000.
Aphria completes acquisition of Nuuvera
Aphria (TSX: APH; OTC: APHQF) closed acquisition of Nuuvera (TSX-V: NUU). Former Nuuvera shareholder will receive $0.62 in cash, rather than $0.60, as previously announced, plus 0.3546 of a common share of Aphria, for each Nuuvera share held
Route1 completes Group Mobile acquisition
Route1 Inc. (OTCQB: ROIUF; TSX-V: ROI) closed on the acquisition of Group Mobile Int’l, LLC from XpresSpa Group, Inc.
Two Owls Ventures closes IPO
Two Owls Ventures Corp. (TSX-V: OWL.P) closed initial public offering of 4,000,000 common shares at $0.10 per share for gross proceeds of $400,000. Leede Jones Gable Inc. acted as agent for the IPO
Profound Medical completes $34.5M bought deal
Profound Medical Corp. (TSX-V: PRN; OTCQX: PRFMF) closed previously announced bought for gross proceeds of $34.5M. Canaccord Genuity Corp. led the offering
